XBKK
VIH
Market cap152mUSD
Nov 12, Last price
8.15THB
Name
Srivichai vejvivat PCL
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Srivichaivejvivat Public Company Limited, together with its subsidiaries, engages in the hospital business in Thailand. The company offers medical services, such as accidental and emergency center, pediatric clinic, obstetrics and gynecology center, orthopedic center and joint center, stroke system center, health checkup center, gastroenterology and hepatology clinic, internal medical clinic, cardiovascular center, vascular surgery, endoscopic surgery center, neurological and brain clinic, dental clinic, x-ray center, breast clinic, dialysis center, occupational medical clinic, women’s disease laparoscopic surgery, social security clinic, physical therapy, skin and laser surgery clinic, plastic surgery clinic, kidney stones and prostate disease center, cancer clinic, radiotherapy center, child development center, sports medicine center, wellness and anti- aging health center, traditional Chinese medicine center, infertility treatment center, mother and child health center, health and occupational health examination center, mobile medical unit, fah sai and urology clinic, and ear, nose and throat clinic. It also operates a vocational school. Srivichaivejvivat Public Company Limited was founded in 1987 and is based in Krathum Baen, Thailand.
Key people
Saisunee Vanadurongwan
Chief Executive Officer, Executive Vice Chairman of the Board · since 2023
Prut Rojmahamongkol
Deputy Chief Executive Officer, Executive Director · since 2024
Vilawan Vanadurongvan
Deputy Chief Executive Officer, Executive Director · since 2013
Vichai Vanadurongwan
Executive Chairman of the Board · since 2024
Pongsak Vathana
Deputy Chief Executive Officer · since 2024
Mongkon Wanitphakdeedecha
Deputy Chief Executive Officer, Executive Director · since 2011
Chalunthorn Trakulveerasak
Company Secretary · since 2024
Tinnawat Mahatharadol
Non-Executive Director · since 2014
Non-Executive Director · since 2014
Bavornrat Vanadurongwan
Non-Executive Director · since 2023
Jessada Charoenying
Non-Executive Independent Director · since 2024
Virah Mavichak
Non-Executive Independent Director · since 2011
Apichai Nimgirawath
Non-Executive Independent Director · since 2024
Porntep Siriwanarangsun
Non-Executive Independent Director · since 2016
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||